Flo vs Ovia 2026: Privacy, Features & Price Compared

Flo and Ovia are both popular women's health apps, but they serve different markets. Flo is a consumer-first platform with 440 million users, offering period tracking, pregnancy content, community forums, and a health chatbot. Ovia is increasingly an enterprise product — owned by Labcorp, it sells Ovia+ to employers and health plans who want analytics on their employees' reproductive health.

Flo's value proposition is breadth: 70+ symptoms, thousands of articles from 120+ medical experts, and a large community. Ovia's value proposition is pregnancy and fertility support, with three separate apps (Fertility, Pregnancy, Parenting) and employer-sponsored health coaching.

The critical question isn't which app has better features — it's who benefits from your data. With Flo, advertisers benefited (until they got caught). With Ovia, your employer and health plan benefit through Labcorp's enterprise analytics. Both apps monetize user health data as a core part of their business model.

This comparison involves two of the most concerning privacy models in the period tracking industry.

Flo's record is documented in an FTC complaint and a federal class action. The FTC alleged in 2021 that Flo shared menstrual data with Google, Facebook, and analytics firms; Flo settled with no fine and no admission. The class action settled in 2025, with Flo paying $8M. A California jury found Meta liable for eavesdropping on Flo users' data. Flo's track record is the industry's worst.

Ovia's model is different but equally concerning. As a subsidiary of Labcorp — a $15 billion clinical laboratory company — Ovia's business fundamentally depends on monetizing user health data through enterprise partnerships. Ovia+ gives employers and health plans access to employee reproductive health analytics. Mozilla gave Ovia a "Privacy Not Included" rating. Snopes confirmed mandatory location data collection.

The distinction matters: Flo was accused of sharing data without permission. Ovia's data sharing is the business model — it's designed to flow to corporate partners. For users, the result is the same: your most intimate health information exists on servers controlled by companies with financial incentives to use it.

PinkyBloom has no corporate parent and no enterprise customers. Your cycle log is stored on your phone, protected by your phone's own encrypted storage and Face ID.

Flo covers more ground: 70+ symptoms, AI chatbot, community forums, pregnancy mode, and content from medical experts. It's designed as an all-in-one health platform.

Ovia focuses on the fertility-to-parenting journey with three dedicated apps and daily fertility scores. The employer-sponsored Ovia+ tier adds health coaching. However, the intelligence layer is content-driven — articles, tips, and milestone tracking — rather than AI-powered. The three-app structure fragments the user experience.

PinkyBloom consolidates all life stages into a single app with genuine AI intelligence. Voice logging captures symptoms hands-free. AI mood forecasts predict emotional patterns. The doctor visit report generator creates professional health summaries. Encrypted partner sharing through PinkyBond replaces cloud-based sharing features.

Flo's premium costs ~$49.99/year with a free ad-supported tier. Ovia's consumer app is free, but the "free" is subsidized by employers paying Labcorp for access to employee health analytics. When a $15B lab corporation gives you a free app, you are the product.

The pricing comparison is actually about hidden costs. Flo's hidden cost surfaced in an FTC complaint and a class action: your data shared with advertisers. Ovia's hidden cost is by design: your reproductive health data flowing to your employer's analytics dashboard.

No ads, no employer partnerships, no corporate parent company. The total cost — financial and otherwise — is zero.